Analytical Data
-
基因名
TPP2
- Application
-
别名
TPP2；Tripeptidyl-peptidase 2
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P29144
-
表达区间
44-264aa
-
氨基酸序列
DTGVDPGAPGMQVTTDGKPKIVDIIDTTGSGDVNTATEVEPKDGEIVGLSGRVLKIPASWTNPSGKYHIGIKNGYDFYPKALKERIQKERKEKIWDPVHRVALAEACRKQEEFDVANNGSSQANKLIKEELQSQVELLNSFEKKYSDPGPVYDCLVWHDGEVWRACIDSNEDGDLSKSTVLRNYKEAQEYGSFGTAEMLNYSVNIYDDGNLLSIVTSGGAH
-
分子量
31.8 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on TPP2 (Tumor Protein 63) recombinant proteins has garnered significant attention due to their role in various biological processes and potential implications in cancer therapy. TPP2 is part of the p53 tumor suppressor gene family and is implicated in cell cycle regulation, apoptosis, and embryonic development. Its dysregulation has been associated with numerous malignancies, underscoring the importance of understanding its function and interactions at a molecular level. Recent advances in recombinant DNA technology have facilitated the production of TPP2 proteins in heterologous systems, allowing for more efficient exploration of their structure and function. These recombinant proteins can be utilized to elucidate the mechanistic pathways involved in tumorigenesis, assess potential drug interactions, and develop targeted therapies. Furthermore, by studying TPP2 in a controlled laboratory setting, researchers can identify novel biomolecular targets and therapeutic strategies to combat various cancers. As the understanding of TPP2's role in cellular mechanisms deepens, it holds promise for enhancing our comprehension of tumor biology and improving clinical outcomes in cancer treatment. Thus, the exploration of TPP2 recombinant proteins represents a pivotal area of research in molecular oncology and therapeutic development.
